Tag Archives: #Warning Letter

It Finally Happened – FDA’s OPDP Issues First Letter of 2023

For those who are regular followers of what FDA’s Office of Prescription Drug Promotion (OPDP) is up to, there was a surprise this week when the office posted the first regulatory action letter – in this case an Untitled Letter … Continue reading

Posted in Warning Letters | Tagged , , , | Comments Off on It Finally Happened – FDA’s OPDP Issues First Letter of 2023

OPDP Issues First Regulatory Action Letter of 2022

FDA’s Office of Prescription Drug Promotion (OPDP) issued the first regulatory action letter for 2022. This one has some notable characteristics. As has been frequently noted, enforcement actions by OPDP have diminished considerably over the years. Another characteristic of recent … Continue reading

Posted in Warning Letters | Tagged , , , | Comments Off on OPDP Issues First Regulatory Action Letter of 2022